DrugDashboards

Losartan Potassium

Losartan Potassium · LOSARTAN POTASSIUM 50 mg/1 · Tablet · Oral · Remedyrepack Inc.

NDC 70518-3282-00 · 60 TABLET in 1 BLISTER PACK · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for losartan potassium (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA078232
TE code
AB
Approval date
Oct 6, 2010
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedApr 6, 2022
    RemedyRepack Inc. — CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Manufacturers of Losartan Potassium (Tablet)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackLOSARTAN POTASSIUM 25 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackLOSARTAN POTASSIUM 50 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsLOSARTAN POTASSIUM 50 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsLOSARTAN POTASSIUM 25 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsLOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 2, 2026
AiPing Pharmaceutical, Inc.LOSARTAN POTASSIUM 25 mg/1Jul 15, 2026Sep 2, 2026
AiPing Pharmaceutical, Inc.LOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 2, 2026
AiPing Pharmaceutical, Inc.LOSARTAN POTASSIUM 50 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCLOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 2, 2026
Jubilant Cadista Pharmaceuticals Inc.LOSARTAN POTASSIUM 25 mg/1Jul 15, 2026Sep 2, 2026
Jubilant Cadista Pharmaceuticals Inc.LOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 2, 2026
Jubilant Cadista Pharmaceuticals Inc.LOSARTAN POTASSIUM 50 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.LOSARTAN POTASSIUM 50 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.LOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.LOSARTAN POTASSIUM 25 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.LOSARTAN POTASSIUM 50 mg/1Aug 12, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.LOSARTAN POTASSIUM 50 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.LOSARTAN POTASSIUM 100 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.LOSARTAN POTASSIUM 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Losartan Potassium — NDC 70518-3282-00," retrieved September 3, 2026, https://drugdashboards.com/drug/70518328200.

Free to cite with attribution — see how the data is put together.